COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
- Sales of rhCollagen and bioinks primed for augmentation following new U.S.-based commercial executive hire -- Raised $3.6 million in registered...